VIP and cancer: The Pharmacogenomics Knowledge Base has designated a category of cancer cell genes as Very Important Pharmacogenes (VIPs) Cancer Genome, because they impact tumor pharmacogenomics and offer current and future biomarker drug targets.20 The molecular testing or profiling of cancer genomes for VIP gene variants as well as other diagnostic biomarkers is often required to select treatment, predict response, and assess drug resistance.